UNSPSC 51161559: Cromitrile

This classification denotes an anti-asthmatic agent with the molecular formula C20H15N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, W6V355N614 chemically known as benzonitrile, 4-(2-hydroxy-3-((4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-5-yl)oxy)propoxy)-, (+/-)- but generally known as cromitrile, which bears US NIH Compound Identifier 40857. European Medicines Agency schedules Cromitrile in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06823MIG.

UNSPSC 51161559 Cromitrile, a Commodity code, covers pharmaceutical raw materials and active pharmaceutical ingredients supplied through state and local cooperative purchasing vehicles. State and local governments buy cromitrile and related chemical compounds as precursors or intermediates for pharmaceutical manufacturing and finished-product formulation, typically sourced through multi-state purchasing alliances and cooperative agreements that aggregate demand across participating state departments, counties, municipalities, and other public health and correctional facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary repeat buyer under this code, managing procurement across multiple states including Oregon through centralized RFPs that establish blanket contracts with multiple manufacturers and authorized wholesalers.

MMCAP issued a Request for Proposal in January 2026 for generic multi-source pharmaceuticals and over-the-counter products with a response due date of March 26, 2026. The solicitation requires vendors to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and mandates compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), with all products available by May 15, 2026 and contract awards effective July 1, 2026. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers, carry comprehensive insurance including $5,000,000 commercial general liability coverage, and accept a 3 percent administrative fee on all contract purchases. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and 5 percent each on administrative fee compliance, EDI capability, and acceptance of the 3 percent administrative fee. The contract term runs two years for new responders with optional extensions at MMCAP's discretion, while incumbent responders' amendments extend through June 30, 2028.